Local view for "http://purl.org/linkedpolitics/eu/plenary/2001-11-14-Speech-3-032"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20011114.2.3-032"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
"Mr President, in line with Lisbon and Stockholm Summit declarations and with the report of this Parliament on the future of the biotech industry, the life sciences are a top priority of the Sixth Framework Programme. This priority is upheld in Mr Caudron's excellent report. Parliament must continue to be consistent and add its support to the progress which our scientists and researchers can provide.
Yet as representatives of the people of Europe, we in this Parliament must also define the limits which will provide an appropriate ethical context for this progress. Genetic research promises much in preventing and curing many of man's most dreaded hereditary diseases. But genetic engineering for this purpose must not extend into eugenics. Embryo research must not lead to the deliberate creation of embryos for research, though we may accept that early stage supernumerary embryos genuinely resulting from in-vitro fertilisation, from spontaneous miscarriages or from therapeutic abortions for the mother's health, and which are destined for destruction in any case, can legitimately and ethically be available for research in Member States where there is strict regulation and supervision.
The amendment submitted by Mr Trakatellis, Mr Nisticò and myself – No 333 – seeks to restrict and define more exactly than the existing text where these limits lie. I commend it to the Parliament."@en1
|
| lpv:spokenAs | |
| lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples